Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03232411 · ClinicalTrials.gov registry record
Biobank for African American Prostate Cancer Research in Florida
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 592
- Enrollment target
NCT03232411 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 592 participants.
The verdict
NCT03232411 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 592 participants
- Enrollment target
Study Summary
The purposes of this study are: a) to develop a statewide Biobank for prostate cancer among men of African Ancestry in Florida and; b) to examine whether smoking increases the aggressiveness of prostate cancer using several biological approaches. Investigators plan to contact African American prostate cancer patients regarding participation. This project has 3 main components. Eligible patients may choose to participate in any or all parts of the study: Questionnaires; Saliva Samples; Tumor Tissue.
Interventions
- OTHER Questionnaires
- OTHER Saliva Samples
- OTHER Tumor Tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 592 participants |
| Start Date | 2017-03-22 |
| Est. Completion | 2024-01-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03232411
The ClinicalTrials.gov registry entry for NCT03232411 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 592 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.
NCT03232411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03232411 about?
NCT03232411 is a clinical study titled "Biobank for African American Prostate Cancer Research in Florida". The purposes of this study are: a) to develop a statewide Biobank for prostate cancer among men of African Ancestry in Florida and; b) to examine whether smoking increases the aggressiveness of prostate cancer using several biological approaches. Investigators plan to contact African American prost...
What is the current status of trial NCT03232411?
This trial is currently completed. The enrollment target is 592 participants. The study started on 2017-03-22. Estimated completion is 2024-01-23.
What interventions are being tested in trial NCT03232411?
The interventions under investigation include: Questionnaires (OTHER), Saliva Samples (OTHER), Tumor Tissue (OTHER).
Who is sponsoring clinical trial NCT03232411?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.